DrugBiological

OBI-833 clinical trials

studies test it: 4
open now: 3
in phase 3: 0
first study started: 2015

Keep track of what changes. Save the OBI-833 studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.

Watch these studies

How studies write it

Studies that test it under each name

Combined with it in one product

OBI-833/OBI-821: 3
Globo H-CRM197: 1
30 μg OBI-833/100 μg OBI-821: 1

Studies by the year they started

4 studies that test it; most in 2022 (2)

Studies that test OBI-833, by start year
Year	Studies
2015	1
2022	2
2024	1

By phase

A phase 1/2 study counts in both.

Phase 1: 2
Phase 2: 2

What it is tested for

Each study’s main condition, where its own words name it.

Stomach Neoplasms: 1
Cholangiocarcinoma: 1
Carcinoma, Non-Small-Cell Lung: 1
Esophageal Neoplasms: 1

Who runs them

Industry 2 · Other 2

OBI Pharma, Inc (2) · Chang Gung Memorial Hospital (1) · National Taiwan University Hospital (1)

Often tested with

Tested in the same studies.

OBI-821 (4)

Studies

Open first, then newest update. How each study uses OBI-833 is read from its arms, and is right about nine times in ten.

Testing it · 4

Codes

What other systems call OBI-833 · ClinicalTrials.gg INT017376

UNII (FDA) NC1XBS5AETOBI-833One source FDA
NCI Thesaurus C119745Globo H-DT Vaccine OBI-833One source FDA

System	Code	Name there	Checked by
UNII (FDA)	NC1XBS5AET	OBI-833	One source FDA
NCI Thesaurus	C119745	Globo H-DT Vaccine OBI-833	One source FDA

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.